Eli Lilly to offer generic insulin at half price of brand
Pharmaceutical company Eli Lilly will sell a cheaper generic version of its rapid-acting insulin Humalog, according to a statement Monday from Chairman and CEO Dave Ricks.
humalog
First Warn Forecast
